Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain
article
OA: closed
CC0
⤵ 114 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This trial compared 3 months of nafarelin therapy to 6 months for endometriosis-associated pelvic pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- A comparison of nafarelin acetate and danazol in the treatment of endometriosis via openalex
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin via openalex
- Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy via openalex
- Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Nafarelin therapy in endometriosis: Long-term effects on bone mineral density via openalex
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist via openalex
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
- W2407529019 via openalex
- W2409164901 via openalex
- W1988605646 via openalex
- W1641053560 via openalex
- W2417044776 via openalex
- W2477008945 via openalex
Cited by (50)
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- Uterine anteroposterior diameter predicts spontaneous pregnancy outcomes in women under 35 years with adenomyosis: a retrospective study 2025
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? 2023
- Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial 2022
- Medical treatments of endometriosis: a review 2022
- GnRH agonists in the treatment of symptomatic endometriosis: a review 2022
- Cost Estimates Associated with Diagnosis and Treatment of Endometriosis 2022
- Dienogest and the Risk of Reoperation in Endometriosis 2021
- Endometriose Aspectos clínicos do diagnóstico ao tratamento 2021
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials 2020
- Use of GnRH analogue in the endometriosis recurrence after surgery 2020
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
- Endometriosis 2019
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Current and Emerging Therapeutics for the Management of Endometriosis 2018
- Medical and Surgical Management of Endometriosis 2018
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS 2018
- Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma 2018
- Current and emerging treatment options for endometriosis 2018
- A self-administered questionnaire to measure the painful symptoms of endometriosis: Results of a modified DELPHI survey of patients and physicians 2017
- Die medikamentöse Therapie der Patientin mit Endometriose 2017
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review 2017
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy 2017
- Surgery and Endometriosis 2017
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
- Can postoperative GnRH agonist treatment prevent endometriosis recurrence? A meta-analysis 2016
- Efficacy Analysis of an Experience on Development of the Combination Therapy Protocol for Endometriosis Management 2016
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial 2015
- Chronic pelvic pain 2015
- Endometriose 2015
- Medikamentöse Therapie der Endometriose 2014
- National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Endometriosis 2013
- Does Helica treatment of early endometriosis confer short- and long-term benefits in terms of pain relief and sub-fertility? 2013
- Medikamentöse Therapie der Endometriose 2013
- The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age. 2013
- Endometriose 2013
- Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women. 2013
- Integrated Pharmacometrics and Systems Pharmacology Model‐Based Analyses to Guide GnRH Receptor Modulator Development for Management of Endometriosis 2012
- Medikamentöse Therapie der chronischen Endometriose 2011
- Preoperative pain and recurrence risk in patients with peritoneal endometriosis 2010
- Aspectos atuais do diagnóstico e tratamento da endometriose 2010
- An investigation of the surgical treatment of endometriosis 2010
- Chronische Endometriose: medikamentöse Therapie 2010
- The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis 2010
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:11:13.665691+00:00
License: CC0
· commercial use OK